Blinded Study of Topical Investigational Lotion Vs. Approved Cream in Treatment of Plaque Psoriasis

NCT01166646 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: Halobetasol Proprionate Lotion 0.05%
DRUG: Halobetasol Proprionate Cream 0.05%

Sponsor

Therapeutics, Inc.